Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India
Identifieur interne : 000885 ( Main/Exploration ); précédent : 000884; suivant : 000886Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India
Auteurs : Monika Vinish [Inde] ; Sudesh Prabhakar [Inde] ; Madhu Khullar [Inde] ; Indu Verma [Inde] ; Akshay Anand [Inde]Source :
- Journal of Neurology, Neurosurgery & Psychiatry [ 0022-3050 ] ; 2010-02.
Abstract
Background Among several aetiological factors, PARK2 mutations are the most common cause of Parkinson disease (PD) that result in degeneration of dopaminergic neurons in the substantia nigra. Methods In order to examine the contribution of PARK2 mutations and corresponding Parkin expression in blood of North West Indian PD patients, the authors screened 120 000 patients from 2001 to 2006 for features of PD using UK Parkinson disease society brain bank clinical diagnostic criteria (UKPDBBC), and tested PARK2 mutations in 69 of those that fulfilled this criteria. 43 controls lacking extrapyramidal signs were also analysed. Results The PCR analysis revealed the occurrence of homozygous deletions in 28 of 69 samples analysed (40.5%) represented by exon-1 (15.9%), exon-3 (11.5%), and exon-12 (11.5%). Sequencing revealed point mutations in exon 4 and exon 9 in six of these patients (8.7%) including one novel missense Gly1083Trp mutation in one patient. Parkin estimation was done by combination of immunolocalisation and FACS analysis revealing reduced Parkin expression among PD patients. The mutations in exons 1, 3 and 12 among sporadic PD patients were found to be higher among younger onset variants (age<45 years). This report also constitutes the first evidence that PARK 2 mutations contribute to the aberration in Parkin expression in blood leading to PD.
Url:
DOI: 10.1136/jnnp.2008.157255
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India</title><author><name sortKey="Vinish, Monika" sort="Vinish, Monika" uniqKey="Vinish M" first="Monika" last="Vinish">Monika Vinish</name></author><author><name sortKey="Prabhakar, Sudesh" sort="Prabhakar, Sudesh" uniqKey="Prabhakar S" first="Sudesh" last="Prabhakar">Sudesh Prabhakar</name></author><author><name sortKey="Khullar, Madhu" sort="Khullar, Madhu" uniqKey="Khullar M" first="Madhu" last="Khullar">Madhu Khullar</name></author><author><name sortKey="Verma, Indu" sort="Verma, Indu" uniqKey="Verma I" first="Indu" last="Verma">Indu Verma</name></author><author><name sortKey="Anand, Akshay" sort="Anand, Akshay" uniqKey="Anand A" first="Akshay" last="Anand">Akshay Anand</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:81376F1272EC0BC09F706EF23FA90B01AA96422D</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1136/jnnp.2008.157255</idno><idno type="url">https://api.istex.fr/document/81376F1272EC0BC09F706EF23FA90B01AA96422D/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000728</idno><idno type="wicri:Area/Main/Curation">000636</idno><idno type="wicri:Area/Main/Exploration">000885</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India</title><author><name sortKey="Vinish, Monika" sort="Vinish, Monika" uniqKey="Vinish M" first="Monika" last="Vinish">Monika Vinish</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh</wicri:regionArea><wicri:noRegion>Chandigarh</wicri:noRegion></affiliation></author><author><name sortKey="Prabhakar, Sudesh" sort="Prabhakar, Sudesh" uniqKey="Prabhakar S" first="Sudesh" last="Prabhakar">Sudesh Prabhakar</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh</wicri:regionArea><wicri:noRegion>Chandigarh</wicri:noRegion></affiliation></author><author><name sortKey="Khullar, Madhu" sort="Khullar, Madhu" uniqKey="Khullar M" first="Madhu" last="Khullar">Madhu Khullar</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh</wicri:regionArea><wicri:noRegion>Chandigarh</wicri:noRegion></affiliation></author><author><name sortKey="Verma, Indu" sort="Verma, Indu" uniqKey="Verma I" first="Indu" last="Verma">Indu Verma</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh</wicri:regionArea><wicri:noRegion>Chandigarh</wicri:noRegion></affiliation></author><author><name sortKey="Anand, Akshay" sort="Anand, Akshay" uniqKey="Anand A" first="Akshay" last="Anand">Akshay Anand</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh</wicri:regionArea><wicri:noRegion>Chandigarh</wicri:noRegion></affiliation><affiliation><wicri:noCountry code="no comma">E-mail: akshay1anand@rediffmail.com</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2010-02">2010-02</date><biblScope unit="volume">81</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="166">166</biblScope></imprint><idno type="ISSN">0022-3050</idno></series><idno type="istex">81376F1272EC0BC09F706EF23FA90B01AA96422D</idno><idno type="DOI">10.1136/jnnp.2008.157255</idno><idno type="href">jnnp-81-166.pdf</idno><idno type="ArticleID">jnnp157255</idno><idno type="PMID">19734163</idno><idno type="Related-article-Href">10.1136/jnnp.2008.162834</idno><idno type="related-article-ID">RA1</idno><idno type="local">jnnp;81/2/166</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3050</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background Among several aetiological factors, PARK2 mutations are the most common cause of Parkinson disease (PD) that result in degeneration of dopaminergic neurons in the substantia nigra. Methods In order to examine the contribution of PARK2 mutations and corresponding Parkin expression in blood of North West Indian PD patients, the authors screened 120 000 patients from 2001 to 2006 for features of PD using UK Parkinson disease society brain bank clinical diagnostic criteria (UKPDBBC), and tested PARK2 mutations in 69 of those that fulfilled this criteria. 43 controls lacking extrapyramidal signs were also analysed. Results The PCR analysis revealed the occurrence of homozygous deletions in 28 of 69 samples analysed (40.5%) represented by exon-1 (15.9%), exon-3 (11.5%), and exon-12 (11.5%). Sequencing revealed point mutations in exon 4 and exon 9 in six of these patients (8.7%) including one novel missense Gly1083Trp mutation in one patient. Parkin estimation was done by combination of immunolocalisation and FACS analysis revealing reduced Parkin expression among PD patients. The mutations in exons 1, 3 and 12 among sporadic PD patients were found to be higher among younger onset variants (age<45 years). This report also constitutes the first evidence that PARK 2 mutations contribute to the aberration in Parkin expression in blood leading to PD.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Vinish, Monika" sort="Vinish, Monika" uniqKey="Vinish M" first="Monika" last="Vinish">Monika Vinish</name></noRegion><name sortKey="Anand, Akshay" sort="Anand, Akshay" uniqKey="Anand A" first="Akshay" last="Anand">Akshay Anand</name><name sortKey="Khullar, Madhu" sort="Khullar, Madhu" uniqKey="Khullar M" first="Madhu" last="Khullar">Madhu Khullar</name><name sortKey="Prabhakar, Sudesh" sort="Prabhakar, Sudesh" uniqKey="Prabhakar S" first="Sudesh" last="Prabhakar">Sudesh Prabhakar</name><name sortKey="Verma, Indu" sort="Verma, Indu" uniqKey="Verma I" first="Indu" last="Verma">Indu Verma</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000885 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000885 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:81376F1272EC0BC09F706EF23FA90B01AA96422D
|texte= Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India
}}
| This area was generated with Dilib version V0.6.23. |  |